171 related articles for article (PubMed ID: 2950885)
1. Interleukins, interferons and tumor necrosis factor in cancer treatment.
Krigel RL
AAOHN J; 1987 Apr; 35(4):159-62. PubMed ID: 2950885
[No Abstract] [Full Text] [Related]
2. [Interferons, interleukin-2 and tumor necrosis factor. New approaches to cancer therapy].
Oettgen HF
Arzneimittelforschung; 1987 Feb; 37(2A):251-5. PubMed ID: 2436634
[TBL] [Abstract][Full Text] [Related]
3. [Immunotherapy].
Urushizaki I; Niizu Y
Gan No Rinsho; 1986 Aug; 32(10):1100-4. PubMed ID: 2431168
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study on the cytotoxic effects, on various human tumor cell lines, of recombinant human TNF and IFN (alpha, beta, gamma)].
Ogawara M; Sone S; Utsugi T; Nakanishi M; Ogura T
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):741-3. PubMed ID: 3103543
[No Abstract] [Full Text] [Related]
5. [Cytokines and monoclonal antibodies. Immunologic approaches to tumor therapy].
Pfreundschuh M
Fortschr Med; 1986 Dec; 104(47-48):973-6. PubMed ID: 2434398
[No Abstract] [Full Text] [Related]
6. [Progress in the therapy of malignant tumors].
Gropp C
Internist (Berl); 1987 Jan; 28(1):44-52. PubMed ID: 2437067
[No Abstract] [Full Text] [Related]
7. [Immunotherapy of metastatic renal cell cancer].
Manseck A; Wirth M
Urologe A; 1993 Sep; 32(5):360-73. PubMed ID: 7692655
[TBL] [Abstract][Full Text] [Related]
8. [Antitumor activity of recombinant human tumor necrosis factor (TNF)].
Somura K; Nakano K; Abe M; Nakata K; Yoshida H
Gan To Kagaku Ryoho; 1985 Jan; 12(1):160-2. PubMed ID: 3966807
[No Abstract] [Full Text] [Related]
9. [Biotherapy of cancer].
Subirá ML; Brugarolas A
Rev Clin Esp; 1992 Jun; 191(2):102-8. PubMed ID: 1380172
[No Abstract] [Full Text] [Related]
10. Immunological monitoring and clinical trials of biological response modifiers.
Urba WJ; Baseler MW
Cancer Chemother Biol Response Modif; 1990; 11():281-302. PubMed ID: 2121208
[No Abstract] [Full Text] [Related]
11. Biological response modifiers: the new immunotherapy.
Foon KA
Cancer Res; 1989 Apr; 49(7):1621-39. PubMed ID: 2466558
[No Abstract] [Full Text] [Related]
12. Symposium on diagnosis and treatment of cancer. Recent progress.
Jpn J Med; 1988 Feb; 27(1):96-112. PubMed ID: 2452911
[No Abstract] [Full Text] [Related]
13. [Anti-metastatic effect of tumor necrosis factor (TNF)].
Watanabe N; Niitsu Y; Sone H; Neda H; Ishigaki S; Urushizaki I
Nihon Gan Chiryo Gakkai Shi; 1984 Jun; 19(5):1049-54. PubMed ID: 6501993
[No Abstract] [Full Text] [Related]
14. Cytokines.
Holmlund JT
Cancer Chemother Biol Response Modif; 1993; 14():150-206. PubMed ID: 7508728
[No Abstract] [Full Text] [Related]
15. [Development of cancer immunotherapy by a combination of biological response modifiers on the basis of their mechanism of action].
Toge T; Tomota S; Aratani K; Kameda A; Yamada H; Yanagawa E; Hattori T
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1258-63. PubMed ID: 3488023
[TBL] [Abstract][Full Text] [Related]
16. Cytokines and immunological monitoring.
Sosman JA; Sawhaney A
Cancer Chemother Biol Response Modif; 1997; 17():217-86. PubMed ID: 9551216
[No Abstract] [Full Text] [Related]
17. Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models.
Winkelhake JL; Stampfl S; Zimmerman RJ
Cancer Res; 1987 Aug; 47(15):3948-53. PubMed ID: 3496953
[TBL] [Abstract][Full Text] [Related]
18. [The significance and outlook of cytokines in cancer therapy].
Nihon Gan Chiryo Gakkai Shi; 1988 Apr; 23(4):907-15. PubMed ID: 3144574
[No Abstract] [Full Text] [Related]
19. [Biological response modifiers and cancer treatment].
Urushizaki I
Gan No Rinsho; 1989 Jan; Spec No():25-33. PubMed ID: 2464707
[No Abstract] [Full Text] [Related]
20. [Cytokines as immunotherapy in cancer].
van der Schelling GP; Ijzermans JN; Marquet RL; Jeekel J
Ned Tijdschr Geneeskd; 1992 Apr; 136(14):681-5. PubMed ID: 1373229
[No Abstract] [Full Text] [Related]
[Next] [New Search]
